US FDA to discuss advances for post-market device surveillance studies at March workshop
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration is to hold a public workshop on 7 March that explores how to advance the design and methodologies for medical device surveillance studies in the post-market setting1.